George Clinical welcomes the INVICTUS program

George Clinical welcomes the INVICTUS program

George Clinical welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The study, supported by Bayer AG and endorsed by the World Heart Federation, will be conducted by George Clinical in China and reinforces the importance of scientific leadership when undertaking […]

Read More

June 14th, 2016

Clinical trial success in Asia

A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]

Read More

June 7th, 2016

Hong Kong regulatory process for clinical trials has been revised

New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country

Read More

March 23rd, 2015

Does air pollution cause COPD?

Chronic obstructive pulmonary disorder (COPD) is now the third most frequent cause of death in the world; however the cause of this disease for a substantial proportion of patients remains unknown.

Read More

February 25th, 2015

Update to Australia’s R&D tax incentive

The R&D Tax Incentive is a targeted, generous and easy to access entitlement program that helps businesses offset some of the costs of doing R&D. The Program aims to help more businesses do R&D and innovate. It is a broad-based entitlement program. This means that it is open to firms of all sizes in all […]

Read More

June 2nd, 2014

Malaysia

George Clinical has had a long history in Malaysia, where we first started working in 1999. In particular, we have established networks of cardiovascular, diabetes and renal Investigators in this multiracial country which has good clinical trial infrastructure.   Office Locations: Level 15.01, 1 First Avenue, 2A Dataran Bandar Utama, Bandar Utama Damansara, 47800 Petaling […]

Read More

May 27th, 2014

Hong Kong and East Asia

George Clinical East Asia is headquartered in Hong Kong. From this location, we oversee our on the ground operations in Hong Kong, Taiwan and Malaysia; whilst enabling coverage of other South East Asian countries such as Singapore and Philippines.   Office Locations: Units 4305-06, Tower 1, Metroplaza, 233 Hing Fong Road, Kwai Fong, New Territories […]

Read More

May 27th, 2014

India

George Clinical India is headquartered in Bengaluru. From this location, we oversee our operations throughout India which includes an office in Hyderabad and a number of home based personnel. India has a highly skilled, English speaking workforce within an established clinical trials industry. With its large, rapidly urbanizing population, India offers significant patient pools.   […]

Read More

May 26th, 2014

China

George Clinical China is headquartered in Beijing, where we are co-located with our parent organization, The George Institute. From this location, we oversee our operations throughout China which includes an office in Shanghai and a number of home based personnel. With China fast becoming the second largest pharmaceutical market in the world, along with its […]

Read More

May 26th, 2014

Australia

George Clinical is an Australian owned organization headquartered in Sydney, Australia. In Sydney, we are co-located with our parent organization, The George Institute, a world leading medical research institute. From this location, we oversee our operations throughout Asia-Pacific. Australia is an attractive place to conduct clinical research with an efficient regulatory process, highly experienced research […]

Read More

May 26th, 2014

Join our Mailing List


Add George Clinical to your network